Shafaati Maryam, Saidijam Massoud, Soleimani Meysam, Hazrati Fereshte, Mirzaei Rasoul, Amirheidari Bagher, Tanzadehpanah Hamid, Karampoor Sajad, Kazemi Sima, Yavari Bahram, Mahaki Hanie, Safaei Mohsen, Rahbarizadeh Fatemeh, Samadi Pouria, Ahmadyousefi Yaghoub
Department of Microbiology, Faculty of Sciences, Jahrom Branch, Islamic Azad University, Jahrom, Iran.
Department of Medical Biotechnology, School of Advanced Medical Sciences & Technologies, Hamadan University of Medical Sciences, Hamadan, Iran.
Future Virol. 2021 Nov. doi: 10.2217/fvl-2021-0170. Epub 2021 Nov 26.
This article provides a brief overview of DNA vaccines. First, the basic DNA vaccine design strategies are described, then specific issues related to the industrial production of DNA vaccines are discussed, including the production and purification of DNA products such as plasmid DNA, minicircle DNA, minimalistic, immunologically defined gene expression (MIDGE) and Doggybone™. The use of adjuvants to enhance the immunogenicity of DNA vaccines is then discussed. In addition, different delivery routes and several physical and chemical methods to increase the efficacy of DNA delivery into cells are explained. Recent preclinical and clinical trials of DNA vaccines for COVID-19 are then summarized. Lastly, the advantages and obstacles of DNA vaccines are discussed.
本文简要概述了DNA疫苗。首先,描述了基本的DNA疫苗设计策略,然后讨论了与DNA疫苗工业化生产相关的具体问题,包括质粒DNA、微型环DNA、简约型、免疫定义基因表达(MIDGE)和Doggybone™等DNA产品的生产和纯化。接着讨论了使用佐剂增强DNA疫苗的免疫原性。此外,还解释了不同的递送途径以及几种提高DNA递送至细胞效率的物理和化学方法。随后总结了DNA疫苗针对COVID-19的近期临床前和临床试验情况。最后,讨论了DNA疫苗的优点和障碍。